Ceftizoxime Acid

• Post Date:

  Apr 28,2013

• Expiry Date:

  Apr 28,2014

• Detailed Description:

  Cas No. :68401-81-0 Specs:In house
  Payment Method: L/C T/T
  Name Ceftizoxime acid
  Synonyms :(6R,7R)-7-[[(2Z)-(2-Amino-4-thiazolyl)(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
  Molecular Formula C13H13N5O5S2
  Molecular Weight 383.41
  CAS Registry Number 68401-81-0
  Usage: intermediate for ceftizoxime sodium
  
  Hipharma Limited is high-tech enterprise which sets R&D and production in the integration, specializing in chemical and pharmaceutical APIs and intermediates production and sales, especially in cephalosporin antibiotics field. We have the plant located in Shijiazhuang, hebei province.
  
  At present, we are in a position to supply the following pharmaceutical raw material and intermediates:
  
  1. Ceftizoxime Sodium sterile
  2. Ceftizoxime Acid
  3. Cefoxitin Sodium sterile
  4. Cefoxitin Acid
  5. Cefalotin Acid
  6. Cefoperazone Sodium Sterile
  7. Cefoperazone Acid
  8. Cefepime Sterile with Arginine
  9. Cefotiam Non sterile
  10. Meropenem with Sodium Carbonate Anhydrous
  11. Meropenem Non Sterile
  12. Entecavir
  13. 3-OH Main chain of Cephalosporin CAS no. 54639-48-4
  14. 7-ANCA Main chain of Cephalosporin CAS no. 36923-17-8
  15. 7-ADCA Main chain of Cephalosporin CAS no. 22252-43-3
  
  If you have any question to our company or products, please feel free to contact us.
  

• CAS Registry Number:

  68401-81-0

• Synonyms:

  ;Ceftizoxime acid;(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;7-[[(2Z)-2-(2-azaniumylidene-3H-thiazol-4-yl)-2-methoxyimino-acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate;

• Molecular Formula:

  C₁₃H₁₃N₅O₅S₂

• Molecular Weight:

  383.4028

• Molecular Structure:

  

• Company:

  Hipharma Limited     [ China ]        

• Contact:

  Joyce Wang

• Tel:

  +86-311-66692200

• Fax:

  +86-311-66692200

• Email:

  hipharma.joyce@gmail.com